Pharmaceutical Executive
November 22, 2005
0
0
Pargluva was a bad bet from early on. Analysts say so. Can BMS still save face?
November 22, 2005
0
0
Animal-rights activists call for attacks on testing facilities. Congress calls activists terrorists. Industry leaders propose a response.